Goodman Financial Corp Raises Position in CVS Health Corp (CVS)

Goodman Financial Corp boosted its stake in CVS Health Corp (NYSE:CVS) by 6.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 58,629 shares of the pharmacy operator’s stock after purchasing an additional 3,485 shares during the period. CVS Health comprises about 2.3% of Goodman Financial Corp’s holdings, making the stock its 22nd largest holding. Goodman Financial Corp’s holdings in CVS Health were worth $4,768,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently modified their holdings of the company. Pathstone Family Office LLC lifted its stake in CVS Health by 341.0% in the 2nd quarter. Pathstone Family Office LLC now owns 1,270 shares of the pharmacy operator’s stock valued at $2,353,000 after purchasing an additional 982 shares during the last quarter. Fieldpoint Private Securities LLC raised its stake in shares of CVS Health by 333.3% during the second quarter. Fieldpoint Private Securities LLC now owns 1,300 shares of the pharmacy operator’s stock valued at $105,000 after acquiring an additional 1,000 shares during the last quarter. Arcadia Investment Management Corp MI raised its stake in shares of CVS Health by 119.6% during the third quarter. Arcadia Investment Management Corp MI now owns 1,333 shares of the pharmacy operator’s stock valued at $108,000 after acquiring an additional 726 shares during the last quarter. MPS Loria Financial Planners LLC bought a new position in shares of CVS Health during the second quarter valued at $119,000. Finally, Gemmer Asset Management LLC raised its stake in shares of CVS Health by 15.3% during the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after acquiring an additional 200 shares during the last quarter. 81.62% of the stock is owned by institutional investors and hedge funds.

Shares of CVS Health Corp (CVS) opened at $78.78 on Friday. CVS Health Corp has a 12-month low of $66.45 and a 12-month high of $84.72. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05. The firm has a market cap of $79,800.00, a price-to-earnings ratio of 16.28, a PEG ratio of 1.38 and a beta of 0.90.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.49 by $0.01. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The company had revenue of $46.18 billion during the quarter, compared to analysts’ expectations of $46.17 billion. During the same period in the prior year, the company posted $1.64 earnings per share. CVS Health’s revenue for the quarter was up 3.5% compared to the same quarter last year. research analysts anticipate that CVS Health Corp will post 5.9 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 2nd. Stockholders of record on Wednesday, January 24th will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.54%. The ex-dividend date of this dividend is Tuesday, January 23rd. CVS Health’s dividend payout ratio (DPR) is presently 41.32%.

Several equities analysts have recently issued reports on CVS shares. Jefferies Group set a $76.00 price target on shares of CVS Health and gave the company a “hold” rating in a research note on Monday, December 4th. Royal Bank of Canada started coverage on shares of CVS Health in a research note on Tuesday, September 19th. They set an “outperform” rating and a $95.00 price target for the company. Vetr downgraded shares of CVS Health from a “buy” rating to a “hold” rating and set a $77.11 price target for the company. in a research note on Thursday, January 4th. Robert W. Baird reaffirmed a “hold” rating and set a $77.00 price target on shares of CVS Health in a research note on Friday, October 27th. Finally, UBS Group raised shares of CVS Health from an “outperform” rating to a “strong-buy” rating in a research note on Thursday, January 4th. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $86.66.

In other news, EVP Lisa Bisaccia sold 29,445 shares of the stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $75.00, for a total transaction of $2,208,375.00. Following the completion of the sale, the executive vice president now directly owns 15,556 shares in the company, valued at $1,166,700. The transaction was disclosed in a filing with the SEC, which is available at this link. Corporate insiders own 0.61% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Goodman Financial Corp Raises Position in CVS Health Corp (CVS)” was published by Community Financial News and is owned by of Community Financial News. If you are accessing this piece on another domain, it was stolen and republished in violation of US & international copyright & trademark laws. The original version of this piece can be read at https://www.com-unik.info/2018/01/13/goodman-financial-corp-raises-position-in-cvs-health-corp-cvs.html.

CVS Health Company Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

What are top analysts saying about CVS Health? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for CVS Health and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit